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The neural crest is a multipotent population of cells that arises at the neural plate border in the vertebrate embryo. We have previously
shown that a member of the Sox family of transcription factors, Sox9, is a regulator of neural crest formation in Xenopus, as Sox9-depleted
embryos failed to form neural crest progenitors. Here, we describe experiments that further investigate Sox9 function during neural crest
development. Induction of neural crest progenitors in Xenopus is regulated by Wnt signaling. We show that this process is largely dependent
on Sox9 function as Wnt-mediated neural crest induction is inhibited in the context of Sox9-depleted embryos. Moreover, we demonstrate
that Sox9 functions as a transcriptional activator during neural crest formation. Expression of a construct in which Sox9 DNA-binding
domain (HMG box) is fused to the repressor domain of Drosophila engrailed blocked neural crest formation, thereby mimicking the
phenotype of Sox9-depleted embryos. Finally, using a hormone-inducible inhibitory mutant of Sox9, lacking the transactivation domain, we
show that Sox9 function is required for neural crest specification but not for its subsequent migration.
D 2004 Elsevier Inc. All rights reserved.
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The neural crest is a population of multipotent cells
unique to the vertebrate embryo. At the end of gastrulation,
the neural crest arises at the junction between the
nonneural ectoderm and the neural plate. Later, as the
plate folds into a tube, these cells will leave the dorsal
portion of the neuroepithelium and migrate throughout the0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Richmond, VA 23284, USA.embryo to give rise to a wide variety of cell types
(reviewed in LeDouarin and Kalcheim, 1999). The neural
crest contributes cartilage, bone, and connective tissue to
the face, neurons, and glial cells to the peripheral nervous
system, pigment cells to the skin, as well as mesenchyme
and smooth muscle cells to the cardiovascular system.
Therefore, defects in the specification, migration, or
differentiation of neural crest cells can have dramatic
consequences on many different organ systems (Bolande,
1997).
Several transcriptional regulators have been implicated in
the formation of the neural crest initially based on their
expression in the neural crest-forming region in different
species (reviewed in Gammill and Bronner-Fraser, 2003). In
Xenopus, such factors include Twist (Hopwood et al., 1985),
Snail (Essex et al., 1993), Slug (Mayor et al., 1995), Zic3
(Nakata et al., 1997), Pax3 (Bang et al., 1997), Msx1
(Suzuki et al., 1997), Ets-1 (Meyer et al., 1997), Meis1b
(Maeda et al., 2001), Zic5 (Nakata et al., 2000), FoxD3275 (2004) 93–103
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et al., 2003), Nbx (Kurata and Ueno, 2003), Sox10 (Aoki
et al., 2003; Honore et al., 2003), and cMyc (Bellmeyer et
al., 2003). While these factors have overlapping expres-
sion domains within the neural crest, it is not clear
whether all cells at the neural plate border express the
same repertoire of genes. Interestingly, a number of these
transcription factors have the ability to mutually cross-
regulate their expression (Aoki et al., 2003; Sasai et al.,
2001), suggesting that they might be reciprocally in-
volved in maintaining each other’s expression. This cha-
racteristic has made it very difficult to establish a clear
hierarchy in the genetic cascade leading to neural crest
specification.
With the exception of the transcriptional repressors Slug
and Snail that have been implicated in the control of neural
crest specification and migration in Xenopus (Aybar et al.,
2003; Carl et al., 1999; LaBonne and Bronner-Fraser,
2000), very little is known about the precise mechanism of
action of the other factors expressed at the neural plate
border and the way in which they regulate neural crest
development.
We have previously shown that the Sox family member
Sox9 is required for neural crest formation in Xenopus
using a morpholino-mediated bknockdownQ of Sox9
protein (Spokony et al., 2002). However, this study did
not directly address the specifics of Sox9 function at the
neural plate border. Is Sox9 required for neural crest
induction mediated by Wnt signaling, a well-established
neural crest-inducing signal? Is Sox9 acting as a transcrip-
tional activator in the context of the neural crest as it does
during chondrocyte development (Bell et al., 1997; Ng
et al., 1997), or as a repressor like other neural crest-
specific transcription factors (Aybar et al., 2003; Kurata
and Ueno, 2003; LaBonne and Bronner-Fraser, 2000;
Sasai et al., 2001)? Is Sox9 required for both specification
of the neural crest and its subsequent migration similar to
the Snail-related factors (Aybar et al., 2003; Carl et al.,
1999; LaBonne and Bronner-Fraser, 2000)? Here, we
describe experiments that answer these questions and
thereby further define Sox9 function in the developing
neural crest.Materials and methods
Constructs
Xenopus Sox9 DNA-binding domain (HMG box), aa
130–182, was generated by PCR and cloned into XhoI site
of CS2+VP16-N and CS2+Eng-N (Kessler, 1997). These
constructs are referred as Sox9-VP16 and Sox9-Eng,
respectively. An inhibitory mutant of Sox9 (Sox9DC), in
which the C-terminal domain of Sox9 cDNA is deleted at
position 311aa, was generated by PCR, and a hormone-
inducible construct was generated by fusing Sox9DC to thecoding region of the human glucocorticoid receptor ligand-
binding domain (GR) as described (Gammill and Sive,
1997; Tada et al., 1997). This fusion construct cloned into
pCS2+ is referred as Sox9DC-GR (Saint-Germain et al.,
2004). A dominant-negative Slug construct (D-Slug)
lacking the amino-terminal domain was generated by
PCR as described (LaBonne and Bronner-Fraser, 2000)
and cloned into pCS2+ vector (Aoki et al., 2003). All
constructs were sequenced, and the corresponding proteins
were monitored using an in vitro transcription/translation
coupled rabbit reticulocyte lysate system in the presence of
[35S]methionine (Promega) and resolved on a NuPAGE
BIS-Tris gel (Invitrogen).
Western blot analysis
In vitro transcription/translation was performed in the
presence of unlabeled methionine and resolved on a
NuPAGE BIS-Tris gel. The gel was blotted onto nitro-
cellulose and incubated in the presence of a pan-Sox
antibody (CeMines, Evergreen, CO; AB/HMG4), at a
1:1000 dilution. This antibody commercialized as a
bSox10-specific antibodyQ cross-react with several Sox
proteins, including Sox2, Sox8, and Sox9 (not shown), as
the antibody was raised against a portion of Sox10 HMG
box, highly conserved among several Sox family members.
After extensive washes, the blot was incubated with
antirabbit Ig coupled to horseradish peroxidase (Amersham
Pharmacia Biotech, 1:60,000 dilution). The product of the
reaction was revealed using the SuperSignal West Femto
Maximum Sensitivity Substrate from Pierce and detected
by exposure onto a BioMax film (Kodak).
Injections and dexamethasone treatment
Xwnt-3A (0.1 ng; Wolda et al., 1993), noggin (0.2 ng;
Smith and Harland, 1992), Sox9-Eng (0.4 ng), Sox9-
VP16 (0.4 ng), Sox9DC-GR (1 ng; Saint-Germain et al.,
2004), and DSlug (1–2 ng; Aoki et al., 2003; LaBonne
and Bronner-Fraser, 2000) mRNAs were synthesized in
vitro using the Message Machine kit (Ambion, Austin,
TX). Sox9 morpholino antisense (Sox9-AS, 10 ng,
Spokony et al., 2002) and control morpholinos, a five-
base pair mismatched Sox9 morpholino (Saint-Germain et
al., 2004), or a standard control morpholino (Co-AS, 10
ng) were obtained from GeneTools (Corvallis, OR).
Synthetic mRNAs, plasmid DNA, and morpholinos were
injected in one blastomere at the two-cell stage. For
plasmid injections, Xwnt-1 (0.1 ng) and Xwnt-3A (0.1
ng) cloned into CS2+ were used (Saint-Jeannet et al.,
1997). In all experiments, embryos were coinjected with
h-galactosidase mRNA (h-gal, 1 ng) as a lineage tracer.
Embryos injected with Sox9DC-GR mRNA were treated
at different time points (stage 6, 8, 10, 12, 14, 17, 20, or
22; Nieuwkoop and Faber, 1967) with 10 AM of
dexamethasone (Sigma) in 0.1 NAM as described
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Germain et al., 2004; Tada et al., 1997). Embryos at
stages 15/17 or 25 were fixed in MEMFA (Harland,
1991) and successively processed for Red-Gal (Research
Organics) staining and in situ hybridization.
Whole-mount in situ hybridization
Antisense DIG-labeled probes (Genius kit, Roche) were
synthesized using template cDNA encoding Slug (Mayor
et al., 1995), Snail (Essex et al., 1993), AP2 (Luo et al.,
2003), Pax3 (Bang et al., 1997), Twist (Hopwood et al.,
1985), Sox2 (Mizuseki et al., 1998), or Sox10 (Aoki et al.,
2003). Whole-mount in situ hybridization was performed
as described (Harland, 1991).
Analysis of gene expression by real-time RT–PCR
Both blastomeres of two-cell stage were injected in the
animal pole region with Xwnt-3A (0.1 ng), noggin (0.2
ng) and DSlug (2 ng) mRNAs, and 10 ng of morpholinos
(Co-AS or Sox9-AS). Animal explants were dissected at
the blastula stage and cultured in vitro until equivalent
stage 17. Real-time RT–PCR (LightCycler, Roche) was
performed using the following primers: EF-1a (forward
primer: ACCCTCCTCTTGGTCGTTTT; reverse primer:
TTTGGTTTTCGCTGCTTTCT; 134 nt), Slug (forward
primer: CATGGGAATAAGTGCAACCA; reverse primer:
AGGCACGTGAAGGGTAGAGA; 120 nt), Snail (forward
primer: TCACAAAGGCAGTGCTTCAC; reverse primer:
TTGTTCTCTGTGCCAACTGC; 116 nt), and Sox9 (for-
ward primer: CACATTTGGGGAAAACTGCT; reverse
primer: CCCTGTAAAAGGCAATGGAA; 103 nt). The
cycle conditions were as follows: denaturation at 958C
(4 s), annealing at 608C (9 s), and extension at 728C
(14 s). By optimizing primers and reaction conditions, a
single specific product was amplified as confirmed by
melting curve analysis. Water blank and RT reactions
were also performed as negative controls. To quantify
expression levels relative to control, serial dilutions of
RNA extracted from Wnt-3A+noggin-injected explants
were used as concentration standards in each real-time
RT–PCR reaction. In each case, EF1a was used as a
loading control (data not shown), and each bar on the
histograms was normalized to the level of EF1a.Results
Wnt-mediated neural crest induction depends on Sox9
function
Because Wnt signaling has been implicated in neural
crest induction in several species (reviewed in Wu et al.,
2003; Yanfeng et al., 2003), we tested the requirement of
Sox9 function for Wnt-mediated neural crest induction. Tothis end, we analyzed the ability of Wnt-1 and Wnt-3A to
generate neural crest progenitors in the context of Sox9-
depleted embryos (Sox9-AS; Spokony et al., 2002).
Injection in one blastomere at the two-cell stage of plasmid
DNA (used instead of RNA to avoid axis duplication)
encoding Wnt-1 or Wnt-3A in combination with a control
morpholino (Co-AS) resulted in a dramatic expansion of
Slug and Snail expression domain in a large proportion of
embryos (Figs. 1A, B). This phenotype is consistent with
previous reports (Luo et al., 2003; Saint-Jeannet et al.,
1997). However, Wnt-1- or Wnt-3A-mediated Slug and
Snail expansion was strongly inhibited, and in the most
extreme cases, Slug and Snail expression was completely
abolished, in the context of Sox9-depleted embryos (Figs.
1A, B). The requirement of Sox9 for neural crest induction
by Wnt signaling was also analyzed in the context of animal
explants (Fig. 1C). Wnt activation in conjunction with
attenuation of bone morphogenetic protein (BMP) signaling
can induce Slug, Snail, and Sox9 expression in animal
explants (Fig. 1C; LaBonne and Bronner-Fraser, 1998; Luo
et al., 2003; Saint-Jeannet et al., 1997). We found that in the
context of Sox9-depleted animal explants, coinjection of
Wnt-3A and noggin failed to activate Slug and Sox9
expression (Fig. 1C). The reduction in Sox9 expression in
these explants is consistent with the observation that Sox9-
AS can block Sox9 expression in whole embryo (not
shown), indicating that Sox9 regulates its own expression.
In contrast to these results Snail expression was not reduced
in these explants, suggesting that Wnt-mediated Snail
induction can occur independently of Sox9 function or that
Snail and Slug/Sox9 respond to different levels of Sox9
protein. Moreover, the increase in Snail expression observed
indicates that Sox9 may have a role in repressing Snail
expression in this type of preparation.
Altogether, these results indicate that Sox9 function is
implicated in Wnt-mediated neural crest induction in both
the whole embryo and animal explants, thereby positioning
Sox9 as a key regulator of neural crest specification,
downstream of Wnt signaling. The difference in the
regulation of Snail in the context of Sox9-depleted
embryos and animal explants may suggest that other
factors, absent in animal explants, contribute to the control
of Snail expression in the whole embryo.
Regulation of Sox9 expression by Slug
We next analyzed the regulation of Sox9 and Snail by
Slug. Injection of a dominant negative Slug mRNA, DSlug
(Aoki et al., 2003; LaBonne and Bronner-Fraser, 2000),
resulted in a reduction of Slug (74%, n=62) and Sox9 (52%,
n=63) expression (Fig. 2A; LaBonne and Bronner-Fraser,
2000). In contrast, Snail expression was either unaffected
(31%) or mildly expanded (52%) in these embryos (n=63;
Fig. 2A). The regulation of Sox9 and Snail by Slug was also
analyzed in the context of animal explants (Fig. 2B). We
found that the injection of DSlug blocked Wnt-3a-mediated
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expression appeared to be increased (Fig. 2B).
These results, together with the observation that Sox9
regulates Slug expression (Fig. 1; Spokony et al., 2002),indicate that Sox9 and Slug are likely to be involved in
maintaining each other’s expression. This type of recip-
rocal activation loops has also been implicated in the
induction and maintenance of Zic-r1, FoxD3, Slug, and
Fig. 2. Regulation of Sox9 and Snail expression by Slug. (A) Whole-mount in situ hybridization of embryos injected in one blastomere at the two-cell stage
with 1–2 ng of DSlug mRNA. Slug (74% of the embryos, n = 62) and Sox9 (52% of the embryos, n = 87) expressions are reduced, while Snail expression
domain was either unaffected or expanded (31% and 52% of the embryos, respectively; n = 63). RNA encoding the lineage tracer h-galactosidase was
coinjected to identify the injected side (left side in all panels, arrows). Embryos are viewed from the dorsal side, anterior to the top. (B) Real-time RT–PCR of
control and DSlug-injected animal explants isolated from embryos injected with a combination of noggin and Wnt-3A mRNA. The relative expression levels of
Snail, Slug, and Sox9 are displayed as histograms. In the DSlug-injected animal explants, Wnt-3A/noggin-mediated induction of Slug and Sox9 is blocked.
While Snail remains unaffected. Explants were harvested and analyzed at equivalent stage 17. In each experiment, EF1a is used as a loading control (data not
shown), and each result is normalized to the expression of EF1a. Values (n = 3) are presented as mean F SEM. *P b 0.05 versus noggin+Wnt-3A; **P b 0.1
versus noggin+Wnt-3A. Single injection of DSlug had no effect on the expression of these genes (not shown).
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On the other hand, unlike Slug and Sox9, Snail is not
reduced in these experiments, suggesting that Snail is
probably acting upstream of Slug in the genetic cascade
leading to neural crest formation as previously proposed
(Aybar et al., 2003). The increase in Snail expression is
likely to be an indirect consequence of DSlug-mediated
Sox9 reduction, thereby preventing Sox9 inhibitory activ-
ity on Snail (Fig. 1C).Fig. 1. Wnt-mediated neural crest induction depends on Sox9 function. (A) Whol
two-cell stage with 100 pg of Wnt-1 or Wnt-3A plasmid DNA and 10 ng of So
Slug and Snail expansion mediated by Wnt-1 or Wnt-3A overexpression is blo
tracer h-galactosidase was coinjected to identify the injected side (right side in al
top. (B) Quantification of Slug and Snail in situ hybridization results. The numb
Real-time RT–PCR of control and Sox9-depleted animal explants isolated from
relative expression levels of Snail, Slug, and Sox9 are displayed as histograms.
Slug and Sox9 is blocked, while Snail remains largely unaffected. Explants were
used as a loading control (data not shown), and each result is normalized to the
0.05 versus noggin+Wnt-3A + CoAS. Single injection of Sox9-AS or Co-AS hSox9 functions as a transcriptional activator during neural
crest formation
We next analyzed the nature of the transcriptional activity
of Sox9 in the context of the developing neural crest. The
well-characterized regulatory domains of the herpes simplex
virus VP16 activator and the Drosophila engrailed repressor
were fused to Sox9-HMG box (Fig. 2A; Sox9-VP16 and
Sox9-Eng constructs, respectively). By Western blot analy-e-mount in situ hybridization of embryos injected in one blastomere at the
x9 morpholino antisense (+Sox9-AS) or a control morpholino (+Co-AS).
cked in Sox9-depleted embryos (+Sox9-AS). RNA encoding the lineage
l panels, arrows). Embryos are viewed from the dorsal side, anterior to the
ers at the top of each column indicate the number of cases analyzed. (C)
embryos injected with a combination of noggin and Wnt-3A mRNA. The
In Sox9-depleted animal explants, Wnt-3A/noggin-mediated induction of
harvested and analyzed at equivalent stage 17. In each experiment, EF1a is
expression of EF1a. Values (n = 4) are presented as mean F SEM. *P b
ad no effect on the expression of these genes (not shown).
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transcription/translation reactions directed by Sox9, Sox9-
Eng, and Sox9-VP16 cDNAs (Fig. 3B). The activity of these
fusion proteins was subsequently tested for their ability to
affect formation of cells at the neural plate border as
determined by Slug, Snail, Sox10, and Sox2 expression at
stages 15/17. Our results indicate that injection of the
repressor domain fusion, Sox9-Eng, blocks Slug, Snail,
and Sox10 neural crest expression while expanding the
expression domain of the neural plate marker Sox2 (Fig. 3C),
thereby replicating the phenotype of Sox9-depleted embryos
(Fig. 2B, Sox9-AS; Spokony et al., 2002). However, because
the HMG box is very highly conserved among Sox proteins
of the E subgroup, we cannot exclude the possibility that
Sox9-Eng fusion may also interfere with Sox8 and Sox10
function in these embryos.
In contrast, injection of the activator domain fusion,
Sox9-VP16, had very little effect on the expression of Slug,
Snail, Sox10, and Sox2. Since overexpression of wild-type
Sox9 leads to a moderate expansion of Slug and Sox10
expression domain (Aoki et al., 2003; Spokony et al., 2002),
the lack of activity of Sox9-VP16 may suggest that domains
outside the HMG box might be needed in addition to the
transactivation domain to fully recapitulate the activity of
wild-type Sox9. Alternatively, the VP16 domain used in this
study may not be a strong enough activator to mimic Sox9
gain-of-function phenotype.
We propose that Sox9 acts as a transcriptional activator
in the neural crest-forming region. This result implies that
putative downstream targets of Sox9 should be up-regulated
during neural crest formation.
Sox9 is required for neural crest specification
Our previous work indicated that Sox9 is required for
neural crest formation (Spokony et al., 2002). To further
define the window of time during which Sox9 is
functioning for neural crest development, we generated
an inducible inhibitory mutant Sox9 construct (Sox9DC-
GR) in which the hormone-binding domain of the human
glucocorticoid receptor is fused to a form of Sox9 lacking
the transactivation domain (Fig. 4A; Saint-Germain et al.,
2004). Embryos were injected in one blastomere at the
two-cell stage with 1 ng of Sox9DC-GR mRNA and
treated with dexamethasone at various stages (Fig. 4B).Fig. 3. Sox9 functions as a transcriptional activator during neural crest formation. (A
(blue) was fused in frame to either the repressor domain of engrailed (Sox9-En
Western blot analysis using a pan-Sox antibody a single product is recognized in in
(lane 2), and Sox9-VP16 (lane 3) cDNAs. (C) Whole-mount in situ hybridization
Sox9-AS or 400 pg of mRNA encoding either Sox9-Eng or Sox-VP16. Embryos
neural plate (Sox2) markers at stage 15/17. Sox9-Eng construct blocks expression
plate-specific gene Sox2, thereby mimicking the phenotype of Sox9-depleted em
coinjected to identify the injected side (red staining, left side in all panels, arrows).
the number of embryos analyzed is indicated in the lower right corner (n=), and th
upper right corner.Addition of dexamethasone at the blastula stages (stage 6
or 8) caused a loss of expression of Slug, Pax3, and to a
lesser extent AP2 at stage 17 (Figs. 4C, D). This result is
consistent with the phenotype of Sox9-depleted embryos
previously described (Spokony et al., 2002) and suggests
that this fusion construct is fully active in blocking Sox9
function. Dexamethasone treatment at the gastrula stage
(+Dex stage 10 or 12) also resulted in a similar loss of all
three neural crest markers (Figs. 4C, D). However,
inactivation of Sox9 at the neurula stage (+Dex stage 14)
failed to block Slug, Pax3, and AP2 expression in the
neural crest-forming region (Figs. 4C, D). As a control,
injections of GR mRNA had no effect on endogenous
Slug, Pax3, and AP2 expression after addition of dexame-
thasone (not shown).
These results indicate that Sox9 function is required
before stage 14 to specify the neural crest, consistent with
the timing of neural crest induction in Xenopus.
Sox9 is not required for cranial neural crest migration
Once specified, neural crest cells delaminate in a
rostrocaudal wave and migrate throughout the embryo.
To determine whether Sox9 is also required for subsequent
migration of the neural crest cells, we analyzed the pattern
of expression of AP2 and Twist in the migrating cranial
neural crest of stage 25 embryos in which Sox9 had been
inactivated before neural crest migration (stage 17) or
during the early phase of migration, stage 20, and stage 22
(Sadaghiani and Thiebaud, 1987), thereby bypassing the
early requirement for Sox9 in neural crest specification
(Fig. 5A). All embryos treated with dexamethasone at
stage 17 (n = 52, AP2 and n = 59, Twist), stage 20 (n =
59, AP2 and n = 44, Twist), or stage 22 (n = 52, AP2 and
n = 60, Twist) developed a normal pattern of migrating
cranial neural crest at stage 25 (Fig. 5B). By Western blot
analysis, the levels of Sox9DC-GR protein remained
constant throughout development (not shown; Saint-Ger-
main et al., 2004), and therefore the lack of activity at
these later stages cannot be attributed to a reduced
accumulation of the fusion protein.
These experiments indicate that while Sox9 is required
for specification of the neural crest, their subsequent
migration into the branchial arches can occur independently
of Sox9 function.) Schematic representation of the fusion constructs. The HMG box of Sox9
g, orange) or the activation domain of VP16 (Sox9-VP16, green). (B) By
vitro transcription/translation reactions directed by Sox9 (lane 1), Sox9-Eng
of embryos injected in one blastomere at the two-cell stage with 10 ng of
were analyzed for expression of neural crest (Slug, Snail, and Sox10) and
of the neural crest markers Slug, Snail, and Sox10 and expands the neural
bryos (Sox9-AS). RNA encoding the lineage tracer h-galactosidase was
Embryos are viewed from the dorsal side, anterior to the top. In each panel,
e percentage of embryos exhibiting the phenotype shown is indicated in the
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In this study, we present evidence that the transcriptional
activator Sox9 is strictly required for specification of the
neural crest in Xenopus, downstream of Wnt signaling. Thisis supported by several observations: (i) Wnt-mediated
neural crest induction is largely inhibited in the context of
Sox9-depleted embryos and animal explants; (ii) expression
of a chimeric Sox9-repressor protein blocks neural crest
formation, mimicking the phenotype of Sox9-depleted
Fig. 4. Sox9 is required for neural crest induction. (A) Schematic representation of the hormone-inducible inhibitory mutant Sox9 construct. Sox9 lacking the
transactivation domain (Sox9DC) is fused to the ligand-binding domain of human glucocorticoid receptor (hGR, purple). (B) Experimental timeline. Two-cell
stage embryos are injected in one blastomere with 1 ng of Sox9DC-GR mRNA. Embryos are subsequently incubated with dexamethasone (+DEX) at different
time point during development (stages 6, 8, 10, 12, or 14), and fixed at stage 17 for detection of Slug, Pax3, or AP2 by whole-mount in situ hybridization. (C)
Whole-mount in situ hybridization of embryos injected in one blastomere at the two-cell stage with 1 ng of Sox9DC-GR mRNA and treated with
dexamethasone (+DEX) at the gastrula (stage 10) or neurula (stage 14) stages. Embryos were analyzed for expression of three early neural crest markers (Slug,
Pax3, and AP2) at stage 15/17. Activation of Sox9 inhibitory mutant (Sox9DC-GR) before stage 14 blocks formation of neural crest progenitors. RNA
encoding the lineage tracer h-galactosidase was coinjected to identify the injected side (red staining, left side in all panels, arrows). Embryos are viewed from
the dorsal side, anterior to the top. (D) Quantification of Slug, Pax3, and AP2 in situ hybridization results. The numbers at the top of each bar indicate the
number of cases analyzed. Slug (red bars) and Pax3 (blue bars) expressions were analyzed after treatment with dexamethasone at five time points, stages 6, 8,
10, 12, and 14. AP2 expression (green bars) was analyzed after treatment with dexamethasone at three time points, stages 6, 10, and 14.
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hormone-inducible inhibitory mutant demonstrates that
Sox9 is required for specification of the neural crest but
not its subsequent migration.
Neural crest specification is believed to depend on
multiple signals emanating from the nonneural ectoderm
and/or the paraxial mesoderm. Such factors include mem-
bers of the bone morphogenetic protein (BMP), fibroblast
growth factor (FGF), and Wnt families (reviewed in Knecht
and Bronner-Fraser, 2002; LaBonne and Bronner-Fraser,
1999). The involvement of Wnt signaling in neural crest
induction has been especially well documented in several
species (reviewed in Wu et al., 2003; Yanfeng et al., 2003).
Using a morpholino-mediated bknockdownQ of Sox9 pro-tein, we show that Wnt-mediated Slug induction depends on
Sox9 function in the whole embryo and in neuralized animal
explants. This observation, together with the fact that
ectopic Wnt expression enhances, and lack of Wnt signaling
inhibits, the neural crest expression of both Sox9 and Slug
(Luo et al., 2003), suggests that Sox9 is required upstream
of Slug in the genetic cascade leading to neural crest
formation. This view is consistent with the fact that Sox9
expression precedes that of Slug at the neural plate border;
Sox9 expression is initiated at stage 12 (Spokony et al.,
2002), while Slug is only detectable by stage 12.5 (Aybar
et al., 2003; Linker et al., 2000; Mayor et al., 1995).
However, the Xenopus Slug promoter contains a functional
Tcf/Lef binding site, indicating that Wnt signaling can also
Fig. 5. Neural crest migration occurs independently of Sox9 function. (A)
Experimental timeline. Two-cell stage embryos are injected in one
blastomere with 1 ng of Sox9DC-GR mRNA. Embryos are subsequently
incubated with dexamethasone (+Dex) at different time points during
migration of the neural crest (stages 17, 20, or 22), and fixed at stage 25
for detection of Twist and AP2 in the migrating cranial neural crest by
whole-mount in situ hybridization. (B) AP2 and Twist whole-mount in
situ hybridization of such embryos. Activation of Sox9 inhibitory mutant
(+Dex) after neural crest specification (stage 17 or 22) does not prevent
cranial neural crest cell migration. Note that the extent of migration of
AP2-and Twist-expressing cells in the cranial region is identical in
control (uninjected) and injected sides. RNA encoding the lineage tracer
h-galactosidase was coinjected to identify the injected side (red staining).
Embryos are viewed from the lateral side, anterior to the right (left
panels) or anterior to the left (right panels).
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evidence that the Sox9 promoter contains a similar Tcf/Lef
binding site, but our results predict this possibility. There-
fore, we would like to suggest that Wnt-mediated Slug
induction can occur through both a Sox9-dependent and a
Sox9-independent pathway.
Sox9 has the capability to regulate its own expression
(not shown; Fig. 1C), similar to Slug (LaBonne and
Bronner-Fraser, 2000; Fig. 2A,B). Additionally, Slug and
Sox9 can mutually regulate their expression in a manner
suggesting that they may be involved in maintaining each
other’s expression (Fig. 2A; Aoki et al., 2003). This type of
reciprocal activation loops makes it difficult to separate theinduction of a gene from its maintenance in the context of
some of the experiments described here.
Recently, it has been proposed that Snail precedes Slug in
the regulatory pathway leading to neural crest formation
(Aybar et al., 2003). Using a dominant negative Slug, we
also found that Snail expression can be regulated independ-
ently from Slug in whole embryos and animal explants (Fig.
2). The onset of Snail expression in the prospective neural
crest has been reported at stage 11 (Aybar et al., 2003),
before Sox9 expression, suggesting that Snail may also act
upstream of Sox9 during neural crest formation. This is
consistent with the view that Wnt-mediated Snail induction
in animal explants can occur in the absence of Sox9
function. However, this does not appear to be the case in
whole embryos where endogenous Snail expression as well
as Wnt-mediated Snail induction is blocked in Sox9-
depleted embryos. This apparent discrepancy may reflect a
higher level of complexity in the regulation of genes in the
context of the developing embryo.
While the majority of the Sox proteins possess a classical
activation domain (reviewed in Kamachi et al., 2000), it is
now well established that transcription factors can acquire
repressor or activator activity in different developmental
contexts. For example, this is the case for members of the
TCF family and for the POU domain-containing proteins
(Botquin et al., 1998; Roose and Clevers, 1999). During
cartilage differentiation, Sox9 has been shown to function as
a transcriptional activator by binding and activating the
chondrocyte-specific enhancer of collagen type II (Bell et al.,
1997; Bi et al., 1999; Ng et al., 1997), but nothing is known
about Sox9 transcriptional activity at the neural plate border.
Expression of chimeric Sox9 constructs carrying the well-
characterized regulatory domains of the herpes simplex
virus VP16 activator or the Drosophila engrailed repressor
fused to Sox9 HMG box allowed us to establish that Sox9
also behaves as a transcriptional activator in the context of
the neural crest. The results presented here using the fusion
constructs imply that Sox9 activates target genes in the
neural crest-forming region. Sox9 is the first transcription
factor expressed at the neural plate border reported to act as
a transcriptional activator. Factors such as Slug, Snail,
FoxD3, and Nbx have all been shown to act as transcrip-
tional repressors (Aybar et al., 2003; Kurata and Ueno,
2003; LaBonne and Bronner-Fraser, 2000; Sasai et al.,
2001). The activation of neural crest markers observed upon
Slug, Snail, FoxD3, or Nbx overexpression is therefore
likely to be indirect, presumably through repression of an
inhibitor of neural crest fate.
A number of studies have established Sox9 as a regulator
of neural crest formation in frog (Spokony et al., 2002),
chick (Cheung and Briscoe, 2003), and mouse (Mori-
Akiyama et al., 2003). To further define the window of
time during which Sox9 is functioning during neural crest
formation, we generated a hormone-inducible inhibitory
Sox9 construct (Sox9DC-GR) to produce a temporal
inactivation of Sox9 function. We show that inactivation
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Pax3, or AP2 expression, while inactivation of Sox9 at the
neural plate stage (stage 14) had no effect on the expression
of these markers. The percentage of embryos with reduced
neural crest markers (Slug and AP2) was higher in the
context of dexamethasone treatment performed at stage 10
than at stage 6. This difference may indicate that factors
other than Sox9 are involved in inducing neural crest at
earlier stages or that the inactivation of Sox9 closer to the
time at which neural crest is normally induced can generate
a stronger phenotype. Altogether, these observations indi-
cate that a Sox9-dependent pathway is required for
specification of the neural crest and that the inductive
events involved are taking place before the neural plate
stage, consistent with the timing of neural crest induction in
Xenopus. Conversely, inactivation of Sox9 during the
phases of neural crest migration (stages 17, 20, and 22),
which bypass the early requirement for Sox9, had no effect
on the migration of neural crest in the branchial arches,
based on Twist and AP2 expression. This result indicates
that, unlike Slug and Snail that have been implicated in both
neural crest specification and migration (Aybar et al., 2003;
Carl et al., 1999; LaBonne and Bronner-Fraser, 2000), Sox9
is strictly functioning during the initial stages of neural crest
specification. However, the experiments described here
address primarily the function of Sox9 during migration of
the cranial neural crest; therefore, we cannot exclude the
possibility that Sox9 might be involved in regulating the
migration of a late emerging population of neural crest cells
in the trunk region. Nevertheless, this seems unlikely, as
Sox9 expression is down-regulated in the trunk region
around stage 25 (Spokony et al., 2002) before neural crest
migration at this axial level (Sadaghiani and Thiebaud,
1987). While FoxD3 has been involved in establishing
neural crest fate in frog and chick embryos (Dottori et al.,
2001; Kos et al., 2001; Sasai et al., 2001), its requirement
for neural crest migration is not as firmly established. Gain-
of-function studies in the chick indicate that FoxD3 can
promote the delamination and migration of neural crest cell
from the dorsal neural tube (Dottori et al., 2001; Kos et al.,
2001).
In conclusion, our results demonstrate that Sox9 func-
tions as a transcriptional activator, downstream of Wnt
signaling, strictly to specify the neural crest. The mode of
action of Sox9 is therefore quite distinct from that of most
transcription factors expressed at the neural plate border.
The identification of the transcriptional targets of Sox9
represents an essential step to further our understanding of
the mechanisms involved in the induction of this important
population of cells at the neural plate border.Acknowledgments
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